EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Predictive value of ALBI score in assessing prognosis of NSTEMI: a retrospective cohort study

Xiaoqiang Chen, Xintao Zhou, Chuanglu Zhao, Lishan Chen, Shuyin Wang, Xinwen Min, Jishun Chen, Xiaolei Li

Frontiers in Cardiovascular Medicine · 22.04.2026 · 13

DOI: 10.3389/fcvm.2026.1768037 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.04.2026. Verfasst von Xiaoqiang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to evaluate the predictive value of the albumin-bilirubin (ALBI) score for mortality risk in patients with non-ST-segment elevation myocardial infarction (NSTEMI).

Methods

A retrospective analysis was conducted on 982 patients with NSTEMI. A multivariate Cox proportional hazards model was established to analyze the predictive value of ALBI for mortality after hospital discharge in NSTEMI patients. Additionally, restricted cubic spline (RCS) plots were used to analyze the relationship between ALBI and post-discharge mortality. Operating characteristic (ROC) curves were generated to assess the predictive accuracy of ALBI, and nomograms were constructed to facilitate clinical application in predicting mortality after hospital discharge in patients with NSTEMI.

Results

Among the 982 participants, 62 (6.3%) developed death during the follow-up. In unadjusted Cox regression models, the ALBI index had a hazard ratio (HR) of 5.07 (95% confidence interval CI: 3.13–8.20, P < 0.001). In the adjusted models, the relationship still persisted. Furthmore, a non-linear and dose–response relationship between the ALBI index and the primary endpoint was observed (non-linear P = 0.050, P overall < 0.001). ROC curve analysis revealed good predictive performance for ALBI. The nomogram model correctly separates patients with and without death risk, with an AUC of 0.835. Our model showed improved prediction of death compared to GRACE, or NT-proBNP (all P < 0.05).

Conclusion

ALBI was significantly associated with the risk of out-of-hospital death in NSTEMI patients. The novel nomogram based on ALBI, NT-proBNP, and GRACE scores showed an improvement in predicting mortality.

Schlagwörter

Stichwörter der Autor:innen

ALBIGRACENSTEMImortalitypredicted value

Autor:innen und Institutionen

  • Sinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.

Zitieren

APA

Chen, X., Zhou, X., Zhao, C., Chen, L., Wang, S., Min, X., Chen, J., & Li, X. (2026). Predictive value of ALBI score in assessing prognosis of NSTEMI: a retrospective cohort study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1768037

Vancouver

Chen X, Zhou X, Zhao C, Chen L, Wang S, Min X, et al. Predictive value of ALBI score in assessing prognosis of NSTEMI: a retrospective cohort study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1768037

BibTeX
@article{Chen2026,
  author = {Chen, Xiaoqiang and Zhou, Xintao and Zhao, Chuanglu and Chen, Lishan and Wang, Shuyin and Min, Xinwen and Chen, Jishun and Li, Xiaolei},
  title = {Predictive value of ALBI score in assessing prognosis of NSTEMI: a retrospective cohort study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1768037}
}
Kostenlos starten →